Edison sets a price target of EUR 2.01 for Amoéba

Amoéba, a Chassieu-based greentech company specializing in natural microbiological solutions, has just had its target price set at EUR 2.01 by Edison Group. This represents a potential appreciation of more than 100% compared to the September 5, 2025, price. Edison highlights the growing demand for natural solutions, positive results from preliminary studies, and distribution partnerships as growth drivers.

As a reminder, Amoéba is being monitored by Euroland Corporate, with a target of EUR 1.90, and KBC Securities, which is targeting EUR 1.50. The company, listed on Euronext Growth, is focusing its efforts on the biocontrol and cosmetics markets, with regulatory proceedings underway in Europe and the United States.